CLASS II Device recall · Reported 14 Feb 2018 · FDA Enforcement Report

Rheumatoid Factor (RF) Kit for use on Spaplus recalled

The Binding Site Group is recalling Rheumatoid Factor (RF) Kit for use on Spaplus, Product #LK151.S.A Intended for the, distributed in California. The recall was initiated on 4 Jan 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #416595, Exp. 31/03/2018; UDI #05051700018319
Quantity recalled49 kits to the U.S. office (32 kits further distributed)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0553-2018
FDA event ID
78934
Recalling firm
The Binding Site Group, Birmingham, N/A
Classification
Class II
Status
Terminated
Recall initiated
4 Jan 2018
FDA classified
8 Feb 2018
Reported
14 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Jan 2018Recall initiated by company
8 Feb 2018Classified by FDA+35 days
14 Feb 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The low and high controls for the product are returning results above the assigned values.

Product as listed by the FDA

Rheumatoid Factor (RF) Kit for use on SPAPLUS, Product #LK151.S.A Intended for the quantitative in-vitro measurement of rheumatoid factor in serum using the Binding Site SPAPLUS analyser. Measurement of rheumatoid factor may aid in the diagnosis of rheumatoid arthritis. This test should be used in conjunction with other laboratory and clinical findings

Where it was distributed

US Distribution was made to CA. There was no foreign/military/government distribution.

California

Questions about this recall

Why was it recalled?

The low and high controls for the product are returning results above the assigned values.

Which lots are affected?

Lot #416595, Exp. 31/03/2018; UDI #05051700018319

Where was it sold?

US Distribution was made to CA. There was no foreign/military/government distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Other Medical Devices recalls

All 13,950